Report Categories
View AllRecent Articles
View All
Nvmi Stock Under Pressure On Earnings News 20260403 1
Technology Select Sector SPDR Fund XLK Core Holding Oracle ORCL Secures Strong Bullish Consensus Amid Cloud Growth Momentum
GRC GormanRupp posts 282 percent EPS beat over analyst estimates for Q1 2026 shares climb 324 percent
How Krystal Biotech KRYS earnings power compares to its price 270 20260508
MMTXU Miluna acquisition Corp Units report no quarterly earnings data available shares unchanged
Kevin Warsh Set to Assume Federal Reserve Chairmanship in White House Ceremony
Cheniere Reports Strong Q1 2026 Results Raises FullYear Guidance
Morrisons to Close 100 Stores Amid Rising Cost Pressures
Sensex Dips 142 Points Nifty Holds Above 23900 as Mid and SmallCaps Shine
Nvidia Stock at Critical Juncture Key Technical Level Could Determine Next Move
Zscaler Stock Plunges Over 30 After Disappointing Revenue Outlook
GREEL Q1 2025 Earnings Narrower Loss Surpasses Estimates as Senior Notes Remain Stable
SION Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline
NextPlat Corp NXPL Q1 2026 Earnings Loss per share of 042 stock edges up 155 amid limited disclosure
LAR Q1 2026 Earnings Lithium Developer Misses EPS Estimates Shares Slide on Earnings Miss
FBIO Q4 2025 Earnings Deep EPS Miss Highlights Challenges for PreRevenue Biotech
SBLK Q1 2026 Earnings Strong Beat on EPS as Dry Bulk Market Improves
Nuveen Core Equity Alpha Fund JCE Inches Higher Near Key Resistance Level
Tevogen Bio Holdings Warrant TVGNW Stalls at 004 as Trading Remains Flat
ZOOZ Strategy Ltd Warrant ZOOZW Surges 5789 as Speculative Interest Builds
JELDWEN Holding JELD Edges Higher Approaching Key Resistance Level
Bank of the James Financial Group Inc BOTJ Edges Lower Amid Light Trading Support Levels in Focus
TrueBlue Q1 2026 Earnings EPS Surprises with 979 Beat Amid Labor Market Uncertainty
SEER Q1 2026 Earnings Slight EPS Beat Amidst Quiet Revenue Disclosure
SPRB Q1 2026 Earnings NarrowerthanExpected Loss Fails to Lift Shares as Pipeline Progress Remains Key
MoonLake Immunotherapeutics MLTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline
SPIR Q1 2026 Earnings Earnings Miss Meets Positive Stock Reaction Amid Strategic Shifts
Curis Inc Q1 2026 Earnings Deep EPS Miss as PreRevenue Biotech Continues Development